AIMT - Aimmune Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Aimmune Therapeutics's activity chart (see below) currently has 121 price targets and 100 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 35.39% with an average time for these price targets to be met of 119.43 days.

Most recent stock forecast was given by from WELLS FARGO on 01-Sep-2020. First documented stock forecast 31-Aug-2015.

Best performing analysts who are covering AIMT - Aimmune Therapeutics:

Charles Duncan Vamil Divan Paul Choi Evan Seigerman Derek Archila

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 04-Feb-2020

$34.5

$0.01 (0.03%)

Buy Since 14-Jun-2016

$34.5

$0.01 (0.03%)

$66

Show more analysts

Please expand the browser size to see the chart

What is AIMT (Aimmune Therapeutics) average time for price targets to be met?

On average it took 119.43 days on average for the stock forecasts to be realized with a an average price target met ratio 35.39

Which analyst has the current highest performing score on AIMT (Aimmune Therapeutics) with a proven track record?

Which analyst has the most public recommendations on AIMT (Aimmune Therapeutics)?

has 0 price targets and 0 ratings on AIMT

Which analyst is the currently most bullish on AIMT (Aimmune Therapeutics)?

Jotin Marango with highest potential upside - $45.51

Which analyst is the currently most reserved on AIMT (Aimmune Therapeutics)?

Andrew Fein with lowest potential downside - -$19.49

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?